ethylenediamine (TPEN) for 30 min, 30 M A438079 for 5 min, or 500 M Trolox for 5 min, they were washed with warmed Eagle's minimum essential medium and incubated with 60 M ZnCl 2 for 2 h. They were then treated with or without 1 ng/mL LPS for 22 h. The levels of interleukin-1 beta (IL-1ba), interleukin-6 (IL-6; b), and tumour necrosis factor-alpha (TNFac) were measured using enzyme-linked immunosorbent assays. Data are expressed as the mean ± the standard error of the mean (n = 4). *p < 0.05, significantly different from the control group. The effects of TPEN, A438079, and Trolox on LPS-induced IL-6 secretion from microglia. After microglia had been treated with or without 1 M TPEN for 30 min, 30 M A438079 for 5 min, or 500 M Trolox for 5 min, they were washed with warmed Eagle's minimum essential medium and treated with or without 1 ng/mL LPS for 22 h.
Levels of IL-6 were measured using enzyme-linked immunosorbent assays. Data are expressed as the mean ± the standard error of the mean (n = 3). *p < 0. Zinc-enhanced IL-6 secretion from LPS-treated microglia was not inhibited by lower concentrations of Trolox. After microglia had been treated with or without 100-500 M Trolox for 5 min, followed by 2-h incubation with 60 M ZnCl 2 and one washout, they were treated with 1 ng/mL LPS for 22 h. Levels of IL-6 were measured using enzyme-linked immunosorbent assays. Data are expressed as the mean ± the standard error of the mean (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001 significantly different from the control group. LPS: lipopolysaccharide; IL-6; interleukin-6. The effects of pyridoxal phosphate-6-azo(benzene-2,4-disulfonic acid)tetrasodium salt hydrate (PPADS), a P2X1-3, 5-7 receptor antagonist, and 4-hydroxy-tempo , a ROS scavenger, on zinc-enhanced IL-6 secretion from LPS-treated microglia. After microglia had been treated with or without 30-100 M pyridoxal phosphate-6-azo(benzene-2,4-disulfonic acid)tetrasodium salt hydrate (PPADS) (a) or 25-50 M 4-hydroxy-tempo (b) for 5 min, followed by 2-h incubation with 60 M ZnCl 2 and one washout, they were treated with 1 ng/mL LPS for 22 h. Levels of IL-6 were measured using enzyme-linked immunosorbent assays. Data are expressed as the mean ± the standard error of the mean (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001 significantly different from the control group; # p < 0.05, ## p < 0.01, significantly different from the group pre-treated with zinc followed by LPS stimulation. ZnCl2 Percentage of alternation during a 10-min session in the Y-maze test was measured. Data are expressed as the mean ± the standard error of the mean (n = 5). *p < 0.01, significantly different from the vehicle-treated ischaemic group. #p < 0.05, significantly different from the saline-treated ischaemic group.
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